Sponsor or institution
Clinical trials and research at Taiho Pharmaceutical Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Taiho Pharmaceutical Co., Ltd. that are recruiting, at sites in 5 countries (most in Japan (4), Australia (2), South Korea (2)). By phase: Phase 1 (2), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Futibatinib and immunotherapy with chemo as first-line treatment for advanced biliary tract cancer | Phase 3 | Brisbane and 20 other locations | Recruiting | Jul 17, 2026 |
| Evaluating the safety of AB122 in patients with advanced solid tumors | Phase 1 | Aichi and 8 other locations | Recruiting | Aug 11, 2021 |
| Treatment of advanced solid tumors with RET gene abnormalities using TAS0953/HM06 | Phase 1/2 | Orange, California and 28 other locations | Recruiting | Dec 24, 2020 |
| Testing a new oral medication for patients with Myelodysplastic Syndrome | Phase 1 | Bunkyō City and 9 other locations | Recruiting | Oct 29, 2020 |
All recruiting trials (4)
-
Futibatinib and immunotherapy with chemo as first-line treatment for advanced biliary tract cancer
A first-line treatment test combines Futibatinib with Zimberelimab and Gemcitabine/Cisplatin to see if it improves survival in people with unresectable or advanced biliary tract cancer.
-
Evaluating the safety of AB122 in patients with advanced solid tumors
This study is testing a new drug called AB122 to see if it's safe for people with advanced solid tumors like pancreatic, colorectal, lung, and gastric cancers.
-
Treatment of advanced solid tumors with RET gene abnormalities using TAS0953/HM06
This study is testing a new drug called TAS0953/HM06 to see if it can help people with advanced solid tumors that have RET gene changes.
-
Testing a new oral medication for patients with Myelodysplastic Syndrome
This study is testing a new oral medication for adults with Myelodysplastic Syndrome to see if it works as well as the standard injectable treatment.
Quick answers
How many clinical trials run by Taiho Pharmaceutical Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Japan (4 trials), Australia (2 trials), South Korea (2 trials), United States (1 trial), Thailand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.